A urinalysis is a test that measures elements found in urine, such as electrolytes, hormones, or waste products of metabolism. It is also called urine test and involves a number of tests to detect and measure various compounds that pass through the urine. This examination can help find problems that need treatment, including infections or kidney problems. A urine test includes three parts namely, visual exam, microscopic exam, and dipstick test. Its primary aim is to screen health conditions. The urinalysis is carried out as routine medical checkup, pregnancy check-up, pre-surgery preparation, or on hospital admission to treat various disorders. It may be used to screen for and/or help diagnose conditions such as a kidney disorders, urinary tract infections, liver problems, diabetes or other metabolic conditions, to name a few. Additional tests and clinical valuation are often required to further examine findings of urinalysis and finally diagnose the causes or specific features of core problems. For instance, urine infection is generally identified based on results of urinalysis. Urine culture is frequently ordered as a follow-up test to recognize the bacteria that may be causing the infection.

According to the Centers for Disease Control and Prevention (CDC), as of 2016, around 4.9 million people in the U.S. were diagnosed with kidney disease. The major factors that are driving growth of the market are increasing prevalence of kidney diseases and urinary tract infections, technological advancements, increasing adoption rate of point-of-care urinalysis devices, implementation of Patient Protection and Affordable Care Act (PPACA), increasing healthcare expenditure, and increasing geriatric population.

Global Urinalysis Market Dynamics

According to the Centers for Disease Control and Prevention (CDC), in 2016, around 29.1 million people or 9.3% of the U.S population suffers from diabetes. Increase in the prevalence of chronic diseases and geriatric population will give rise to prevention and cure for the chronic diseases, owing to the growth of urinalysis market. Emergence of portable and battery operated urinalysis devices and increase in implementation of urinalysis in emerging economic countries such as China, India and others, will create new opportunities for the global urinalysis market. Integrated systems & urinalysis via smartphones and technological advancement present opportunities in the market.

High costs of R&D, implementation of excise tax by the U.S. government, and stringent regulatory procedures are major factors that hinder growth of the market. Massive population and the observed high, unmet clinical needs in emerging economies provide the market with a large pool of opportunities for prospective growth. To exploit these opportunities, the development of diagnostic tools that can respond to these unmet clinical needs at reasonable price is mandatory.

Global Urinalysis Market -Regional Analysis

North America holds the largest share in the global urinalysis market. The major drivers are presence of key market players in the region such as Alere, Inc., Bio Rad, Siemens Healthcare, and Beckman Coulter. Moreover, introduction of the automated urine sediment analyzers such as digital flow morphology (digital imaging) & fluorescence flow cytometry together with high healthcare expenditure in this region.

Asia Pacific is expected to observe the fastest growth during the forecast period. Increasing penetration of advanced urine analyzers and presence of local urine analyzer manufacturers, such as Mindray, Urit medical, and a large base of the target population with unmet clinical needs are expected to strengthen the market growth over the forecast period.

Global Urinalysis Market - Competitive Landscape

Key players operating in the urinalysis market are Alere, Bio Rad, Roche Diagnostics, Mindray, Arkray, Inc., Sysmex, and Siemens Healthcare.

Key Development

In January 2019, Bio-Rad Laboratories, Inc., launched, qUAntify Advance Control, an independent quality control used in clinical labs while performing urine test 

In 2018 Beckman Coulter and U.S. ARKRAY, Inc., announced a partnership and introduced iQ Urinalysis Workcell, an automated urine analyzers in the US.

In 2017, U.S. ARKRAY, Inc., launched AUTION ELEVEN AE-4022, a semi-automated urine analyzer.       

In 2014, F. Hoffmann-La Roche Ltd, launched cobas 6500, a fully automated urine testing system consist of two modular analyzer combining urine strip testing and digital urinary microscopy.

In 2014, Transasia Bio-Medicals Ltd., Launched Laura M urine analyzer in India, which  measure all routine parameters in urine along with Microalbumin and Creatinine.

Global Urinalysis Market-Taxonomy

The global urinalysis market is segmented on the basis of product type, test type, end user and region

By Product Type

  • Consumables
  • Instruments

By Test Type

  • Biochemical Urinalysis
  • Sediment Urinalysis

By End User

  • Hospitals
  • Diagnostics Laboratories
  • Research Laboratories and Institutes
  • Home-care Settings

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa